Porphobilinogen serves as a critical intermediate in the heme biosynthesis pathway and acts as a vital diagnostic biomarker in clinical diagnostics. Often referred to as PBG, this organic compound is essential… Read more
Porphobilinogen serves as a critical intermediate in the heme biosynthesis pathway and acts as a vital diagnostic biomarker in clinical diagnostics. Often referred to as PBG, this organic compound is essential for identifying conditions such as acute intermittent porphyria, variegate porphyria, and hereditary coproporphyria, where elevated levels indicate disruptions in hepatic enzyme activity. Laboratories rely on high-quality Porphobilinogen reference standards for accurate analytical testing, method validation, and quality control procedures. Additionally, the availability of stable isotope labelled compounds, such as deuterium or 13C-enriched analogues, provides internal standards that are indispensable for precise quantitative analysis via mass spectrometry. These research-grade materials support comprehensive impurity profiling and rigorous testing protocols required to ensure the reliability of clinical assays and metabolic research studies involving this pathway.